Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

Fig. 2

The main steps in the identification and selection of biomarker candidate proteins for inclusion in the PRM assays. Screenshots are from CSF-PR [14], PPI network is from [5] and other figures are from Servier Medical Art licensed under a Creative Commons Attribution 3.0 Unported License. TMT = tandem mass tag, DDA = data dependent acquisition, MM-RP AX = mixed-mode reversed-phase anion exchange [18], GO = gene ontology, ECM = Extracellular matrix

Back to article page